Korean bio 'Big 3' Samsung, Celltrion, SK to expand their businesses in Songdo

Dec 29, 2021

Seoul [South Korea], December 29 (ANI/Global Economic): As SK Bioscience announced its plan to open a new R&PD center in Songdo, Incheon, three Korean...

SK Bioscience to develop COVID-19 Omicron-specific vaccine

Feb 09, 2022

Seoul [South Korea], February 9 (ANI/Global Economic): As the Omicron COVID-19 variant, which is now the most dominant strain in the world, rapidly spread...

SK Bioscience to invest 150 billion won in vaccine factory expansion

Jun 22, 2021

Seoul [South Korea], June 22 (ANI/Global Economic): SK Bioscience has begun work to become a hub for global vaccine production.

SK Bioscience suspends production of COVID-19 vaccine 'Sky Covione'

Nov 24, 2022

SK Bioscience obtained item approval on June 29 and supplied vaccines on September under a pre-purchase contract with the government, but suspended production due...

South Korea: SK Bioscience to develop COVID-flu combo vaccine

Feb 22, 2022

Seoul [South Korea], February 22 (ANI/Global Economic): As 'flurona,' which means having both COVID-19 and influenza at the same time, is recently popping up...

SK Bioscience to purchase 5 million doses of additional vaccines from Novavax

Jan 03, 2022

Seoul [South Korea], January 3 (ANI/Global Economic): SK Bioscience signed a contract to pre-purchase up to 5 million doses of Novavax's COVID-19 vaccine 'NVX-CoV2373'...